Response to the letter from Dr Cosolo and Colleagues

por Pearson, A.D.J.
Publicado 1992

A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children.

por Lowis, S. P., Price, L., Pearson, A. D., Newell, D. R., Cole, M.
Publicado 1998

p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.

por Jaros, E., Lunec, J., Perry, R. H., Kelly, P. J., Pearson, A. D.
Publicado 1993

Schedule-dependent response of neuroblastoma cell lines to combinations of etoposide and cisplatin

por Meczes, E L, Pearson, A D J, Austin, C A, Tilby, M J
Publicado 2002

Ototoxicity of cisplatinum in children and adolescents.

por Skinner, R., Pearson, A. D., Amineddine, H. A., Mathias, D. B., Craft, A. W.
Publicado 1990

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.

por Gilbertson, R. J., Pearson, A. D., Perry, R. H., Jaros, E., Kelly, P. J.
Publicado 1995

The influence of ifosfamide scheduling on acute nephrotoxicity in children.

por English, M. W., Skinner, R., Pearson, A. D., Price, L., Wyllie, R., Craft, A. W.
Publicado 1997

Dose-related nephrotoxicity of carboplatin in children

por English, M W, Skinner, R, Pearson, A D J, Price, L, Wyllie, R, Craft, A W
Publicado 1999

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.

por English, M. W., Lowis, S. P., Peng, B., Boddy, A., Newell, D. R., Price, L., Pearson, A. D.
Publicado 1996

The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.

por Pearson, A. D., Amineddine, H. A., Yule, M., Mills, S., Long, D. R., Craft, A. W., Chessells, J. M.
Publicado 1991

Cisplatin dose rate as a risk factor for nephrotoxicity in children.

por Skinner, R., Pearson, A. D., English, M. W., Price, L., Wyllie, R. A., Coulthard, M. G., Craft, A. W.
Publicado 1998

Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.

por Peng, B., Tilby, M. J., English, M. W., Price, L., Pearson, A. D., Boddy, A. V., Newell, D. R.
Publicado 1997

Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells

por Armstrong, J L, Ruiz, M, Boddy, A V, Redfern, C P F, Pearson, A D J, Veal, G J
Publicado 2005

Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer

por Willits, I, Price, L, Parry, A, Tilby, M J, Ford, D, Cholerton, S, Pearson, A D J, Boddy, A V
Publicado 2005

Estimation of glomerular filtration rate in paediatric cancer patients using (51)CR-EDTA population pharmacokinetics

por Cole, M, Price, L, Parry, A, Keir, M J, Pearson, A D J, Boddy, A V, Veal, G J
Publicado 2004

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force

por Matthay, K K, Shulkin, B, Ladenstein, R, Michon, J, Giammarile, F, Lewington, V, Pearson, A D J, Cohn, S L
Publicado 2010

Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Children's Cancer Study Group

por Veal, G J, Cole, M, Errington, J, Pearson, A D J, Foot, A B M, Whyman, G, Boddy, A V
Publicado 2007

Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears. United Kingdom Children's Cancer...

por Taylor, C. P., McGuckin, A. G., Bown, N. P., Reid, M. M., Malcolm, A. J., Pearson, A. D., Sheer, D.
Publicado 1994

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the Int...

por Beiske, K, Burchill, S A, Cheung, I Y, Hiyama, E, Seeger, R C, Cohn, S L, Pearson, A D J, Matthay, K K
Publicado 2009

The relationship between intrinsic thymidylate synthase expression and sensitivity to THYMITAQ in human leukaemia and colorectal carcinoma cell lines.

por Estlin, E. J., Balmanno, K., Calvert, A. H., Hall, A. G., Lunec, J., Newell, D. R., Pearson, A. D., Taylor, G. A.
Publicado 1997